Insider Selling: Huron Consulting Group Inc. (NASDAQ:HURN) Director Sells $62,325.00 in Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director John Mccartney sold 500 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.65, for a total value of $62,325.00. Following the sale, the director now owns 56,688 shares of the company’s stock, valued at approximately $7,066,159.20. This represents a 0.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Huron Consulting Group Price Performance

Huron Consulting Group stock opened at $125.68 on Thursday. The firm has a market cap of $2.23 billion, a PE ratio of 27.32 and a beta of 0.60. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The stock’s fifty day moving average price is $122.62 and its two-hundred day moving average price is $111.62. Huron Consulting Group Inc. has a one year low of $84.26 and a one year high of $131.06.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings results on Tuesday, October 29th. The business services provider reported $1.68 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.11. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The company had revenue of $370.00 million for the quarter, compared to analysts’ expectations of $377.63 million. During the same quarter last year, the business earned $1.39 earnings per share. Huron Consulting Group’s revenue was up 3.3% on a year-over-year basis. As a group, research analysts expect that Huron Consulting Group Inc. will post 6.1 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently issued reports on HURN. StockNews.com upgraded Huron Consulting Group from a “hold” rating to a “buy” rating in a research note on Thursday, October 31st. Benchmark reissued a “buy” rating and issued a $140.00 target price on shares of Huron Consulting Group in a research report on Wednesday, October 30th. Finally, Barrington Research raised their price target on shares of Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $133.00.

Hedge Funds Weigh In On Huron Consulting Group

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Huron Consulting Group during the 2nd quarter worth approximately $28,000. Assetmark Inc. boosted its holdings in shares of Huron Consulting Group by 7.0% in the 3rd quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock valued at $149,000 after purchasing an additional 90 shares in the last quarter. MML Investors Services LLC bought a new position in shares of Huron Consulting Group in the 3rd quarter valued at $220,000. Peapack Gladstone Financial Corp bought a new stake in shares of Huron Consulting Group during the 3rd quarter worth $220,000. Finally, Orion Portfolio Solutions LLC acquired a new stake in Huron Consulting Group in the third quarter valued at about $264,000. 93.90% of the stock is currently owned by institutional investors and hedge funds.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.